Axovant and Yposkesi Sign Strategic Gene Therapy Development and Manufacturing Partnership Genetics Investing
Abeona Therapeutics Receives FDA Fast Track Designation for ABO-202 AAV9 Gene Therapy Biotech Investing
Ziopharm Oncology Announces FDA Clearance of IND for Sleeping Beauty TCR-T Cell Therapy Trial Genetics Investing
Homology Medicines Initiates Phase 1/2 Study for HMI-102 Gene Therapy Candidate for Adults with PKU Genetics Investing
Adverum Biotechnologies Doses First Patient in Second Cohort of OPTIC Phase 1 Clinical Trial of ADVM-022 Biotech Investing
